DSP-7888 Dosing Emulsion

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DSP-7888 Dosing Emulsion, covering 2023-01-30 to 2024-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing